Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 148 participants.

Also called NCT02037412

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 148 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02037412
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02037412. Randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2016-09-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
Condition
Acute Coronary Syndrome
Condition
Acute Myocardial Infarction
Condition
Unstable Angina (Intermediate Coronary Syndrome)
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Clopidogrel
Lead sponsor
Yonsei University (class: other)

Record details

Record id
cardio:ct-nct02037412
Content hash
a17a9c8eb0e279fc8bb865e710fe2f648855cfd83239fbe179a492047c7a3f51